HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamine

a proton pump inhibitor; structure in first source
Also Known As:
TAK 438; TAK-438; TAK438; Vonoprazan
Networked: 227 relevant articles (77 outcomes, 75 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Iwakiri, Katsuhiko: 12 articles (02/2022 - 01/2016)
2. Kinoshita, Yoshikazu: 7 articles (01/2022 - 01/2016)
3. Ashida, Kiyoshi: 7 articles (11/2019 - 01/2016)
4. Sakurai, Yuuichi: 7 articles (11/2019 - 01/2016)
5. Nishimura, Akira: 7 articles (04/2018 - 01/2016)
6. Hayashi, Yoshikazu: 6 articles (12/2022 - 09/2017)
7. Osawa, Hiroyuki: 6 articles (12/2022 - 09/2017)
8. Shinozaki, Satoshi: 6 articles (12/2022 - 09/2017)
9. Yamamoto, Hironori: 6 articles (12/2022 - 09/2017)
10. Kawami, Noriyuki: 6 articles (02/2022 - 01/2017)

Related Diseases

1. Gastroesophageal Reflux (GERD)
2. Peptic Esophagitis (Reflux Esophagitis)
3. Infections
4. Ulcer
5. Hemorrhage

Related Drugs and Biologics

1. Proton Pump Inhibitors
2. Acids
3. Potassium
4. Amoxicillin (Wymox)
5. Lansoprazole (Prevacid)
6. Esomeprazole (Nexium)
7. Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
8. Rabeprazole (Aciphex)
9. Bismuth
10. Aspirin (Acetylsalicylic Acid)

Related Therapies and Procedures

1. Therapeutics
2. Esophagectomy
3. Ligation
4. Secondary Prevention
5. Drug Therapy (Chemotherapy)